Abstract
An α-spectrin variant with increased susceptibility to tryptic digestion, α(II/47) was previously observed in a child with severe, recessively inherited, poikilocytic anemia. The molecular basis of this variant, spectrin St Claude, has now been identified as a splicing mutation of the α-spectrin gene due to a T → G mutation in the 3' acceptor splice site of exert 20. This polypyrimidine tract mutation creates a new acceptor splice site, AT → AG, and leads to the production of two novel mRNAs. One mRNA contains a 12 intronic nucleotide insertion upstream of exon 20. This insertion introduces a termination codon into the reading frame and is predicted to encode a truncated protein (108 kD) that lacks the nucleation site and thus cannot be assembled in the membrane. In the other mRNA, there is in-frame skipping of exon 20, predicting a truncated (277 kD) α-spectrin chain. The homozygous propositus has only truncated 277 kD α-spectrin chains in his erythrocyte membranes. His heterozygous parents are clinically and biochemically normal. This allele was identified in 3% of asymptomatic individuals from Benin, Africa.
Cite
CITATION STYLE
Fournier, C. M., Nicolas, G., Gallagher, P. G., Dhermy, D., Grandchamp, B., & Lecomte, M. C. (1997). Spectrin St Claude, a splicing mutation of the human α-spectrin gene associated with severe poikilocytic anemia. Blood, 89(12), 4584–4590. https://doi.org/10.1182/blood.v89.12.4584
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.